Identify The Best Sites, Activate Faster, And Enroll Sooner
Today’s clinical research leaders need to streamline every phase of clinical trial timelines. Ryght’s agentic AI platform makes it easier than ever to find, qualify, and activate high-potential sites faster.

Make it to market faster
Compress Development Timelines
Faster site selection, qualification and activation can compress overall development timelines by 6-12 months per study. For blockbuster drugs, this acceleration can translate to hundreds of millions in additional revenue through earlier market entry.
Maximize Study Success Rates
Ryght AI's precision AI matching ensures optimal alignment between your protocol requirements and site capabilities, leading to higher enrollment rates, better data quality, and reduced study failure risk – protecting your R&D investment.
Enable Portfolio-Wide Optimization
Leverage comprehensive site performance data across your entire development portfolio to identify high-performing sites for future studies, negotiate better terms, and build strategic long-term partnerships that benefit multiple programs.
Lower costs, accelerate collaboration with your CRO, and enroll patients sooner.
Direct platform access means you retain full control over site selection decisions without intermediary interpretation or potential misalignment of priorities. Make real-time adjustments and strategic pivots as your program evolves.
Cut expensive CRO fees and lengthy vendor negotiations. Our AI-powered platform gives you direct access to instant protocol analysis, site identification and feasibility management, reducing reliance on external resources and saving hundreds of thousands in vendor costs per study.
Skip the months-long site identification process. Our platform instantly scans 330,000 AI Site Twins to deliver optimal site matches in minutes, not months, dramatically reducing internal resource allocation and project management overhead.
Advanced AI matching prevents costly site selection errors that lead to poor enrollment, protocol deviations, and study failures. Avoid the expensive consequences of re-screening sites, extending timelines, or adding backup locations mid-study.
6 month site selection timeline compressed to 26 days
A leading global CRO faced a highly complex oncology protocol, a tight timeline, and a target of 13 qualified research sites. Ryght's Protocol-Powered Site Ranking delivered more than triple the goal in only 28 days.
26 Days
From initial kickoff to a finalized qualified site list, all completed in under a month.
43 Sites
The CRO needed 13 qualified sites, they received 43, without compromising site capabilities or investigator fit.
Explore the Ryght platform

Share your protocol and receive a free, ranked & tiered country and site list tailored to your study in under 24 hours.

Level up your site selection with intelligent ranking that tailors your site list to the specific needs of your protocol.

Automatically send AI-powered feasibility questionnaires to qualified sites and track responses in real time.
Available on the Microsoft Azure Marketplace
Ryght is available on Microsoft Azure Marketplace, making it easy for sponsors and CROs to use existing cloud commitments, simplify billing, and increase cost efficiency.

Related resources
Navigating the Life Sciences Landscape: A Conversation with Tom Pike
Ryght's LinkedIn Live session uncovers the forefront of industry trends on the transformative potential of generative AI and its profound impact on shaping tomorrow's medical landscape.
Stay Connected
Subscribe to be the first to know about product updates, news and announcements.